Quarterly EPS analysis of Interpace Diagnostics Group, Inc. (NASDAQ:IDXG)


Valuation Ratios of Interpace Diagnostics Group, Inc. (IDXG) versus the Industry and Sector:

Let’s have a look at some of the important valuation ratios of the Interpace Diagnostics Group, Inc. (IDXG). These ratios are important while doing valuation of the company or the shares of the company.

Interpace Diagnostics Group, Inc. (IDXG) currently has P/E (Price to Earnings) ratio of 0 while the company’s industry has 23.16 P/E and the sector P/E is 21.92. Similarly, the company’s last 5 years high P/E ratio is 0 and low P/E is 0, whereas, the industry’s and sector’s  high P/E for the past year is 32.34 and 45.63 respectively and low P/E ratio for the last 5 years is 15.02 for the industry and 13.61 for the Sector.

Beta is also an important valuation ratio for analyzing the stock of the company, IDXG has Beta of 1.78 while its industry and Sector’s beta remains at 0.75 and 0.93 respectively.

Price to Sale ratio of IDXG stands at 1.53 while Price to Book Ratio stands at 0.64. Its Price to Cash Flow ratio shows the value of 12.51, whereas, the industry and sector ratio of Price to Cash Flow ticked at 15.61 and 17.68 respectively.

5 Year Growth Rate Analysis:

Growth rates are very important while analyzing the long term growth and valuation of a certain company.

5 year sales growth rate is an important factor for valuation analysis, the 5 year sales growth of Interpace Diagnostics Group, Inc. (IDXG) stands at -39.18 while the industry’s and the sector’s growth for next 5 years ticked at 7.34 and 6.69 respectively. The company’s 5 year Earnings per share growth and Capital Spending growth remains at 0 and 0.

Interpace Diagnostics Group, Inc. (IDXG) Trading Statistics:

The company surged 2.55% and closed its last trading session at $2.35. The market capitalization of the company is at $21.18 Million. The stock touched 52-week High of $19.80 on 12/09/16 and 52-week Low of $0.70 on 11/22/16. The stock currently has Weekly Volatility of 10.61% and Monthly Volatility of 8.24%. The Beta for the company stands at 1.82 and its Average True Range (ATR) shows a value of 0.27.